No Intervention Expected	30% Coverage Expected	30% Coverage Incremental
Base Case
Cases	2,785,259	1,399,598	-1,385,661
Hospitalizations	1,670	817	-853
Deaths	67	32	-35
Total Cost	153,899,207	194,790,418	40,891,211
QALYs (undiscounted)	124,932,891	124,957,756	24,864
ICER (Cost/QALY)			1,645
Sensitivity Analysis: Ratio 1/60
Cases	2,785,259	1,399,598	-1,385,661
Hospitalizations	2,783	1,362	-1,421
Deaths	111	53	-58
Total Cost	160,787,889	198,140,762	37,352,874
QALYs (undiscounted)	124,932,053	124,957,349	25,296
ICER (Cost/QALY)			1,477
Sensitivity Analysis: Ratio 1/200
Cases	2,785,259	1,399,598	-1,385,661
Hospitalizations	835	409	-426
Deaths	33	16	-17
Total Cost	148,732,696	192,277,660	43,544,964
QALYs (undiscounted)	124,933,520	124,958,061	24,541
ICER (Cost/QALY)			1,774
Sensitivity Analysis: lower vaccine program effectiveness
Cases	2,785,259	2,099,397	-685,863
Hospitalizations	1,670	1,226	-444
Deaths	67	48	-19
Total Cost	153,899,207	233,374,308	79,475,101
QALYs (undiscounted)	124,932,891	124,945,440	12,549
ICER (Cost/QALY)			6,333
Sensitivity Analysis: high vaccination cost ($50 per person)
Cases	2,785,259	1,399,598	-1,385,661
Hospitalizations	1,670	817	-853
Deaths	67	32	-35
Total Cost	153,899,207	273,205,510	119,306,303
QALYs (undiscounted)	124,932,891	124,957,756	24,864
ICER (Cost/QALY)			4,798